Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123158) titled 'Construction of a precise molecular typing system for 22q11.2 duplication syndrome' on April 22.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The international peace maternity and child health hospital
Condition:
22q11. 2 duplication syndrome
Intervention:
Gold Standard:Chromosome microarray chip or exome sequencing
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-05-01
Target Sample Size: Target condition:50;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=3194...